Role of viruses in the development of breast cancer

Infectious Agents and Cancer

Volumn 8, Issue 1, 2013, Pages

  Alibek, Kenneth ^a,b   Kakpenova, Ainur ^a   Mussabekova, Assel ^a   Sypabekova, Marzhan ^a   Karatayeva, Nargis ^a  

^a NAZARBAYEV UNIVERSITY   (Kazakhstan)

^b National Medical Holding   (Kazakhstan)

Author keywords

Breast cancer; Carcinogenesis; Infectious agents

Indexed keywords

CARCINOGEN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CARCINOGENICITY; CLINICAL EVALUATION; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; INFECTION; INFLAMMATORY BREAST CANCER; LUNG CANCER; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PAPILLOMA VIRUS; POLYOMA VIRUS; PRIORITY JOURNAL; PROVIRUS; RETROVIRUS; SIMIAN VIRUS 40; TUMOR VIRUS; VIRUS;

EID: 84883162802     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-8-32     Document Type: Article

References (70)

1. Cancer facts and figures 2012 http://www.cancer.org/acs/groups/content/ @epidemiologysurveilance/documents/document/acspc-031941.pdf
2. WHO | Cancer http://www.who.int/mediacentre/factsheets/fs297/en/
3. The global health burden of infection-associated cancers in the year 2002. Parkin DM, International journal of cancer Journal international du cancer 2006 118 12 3030 3044 10.1002/ijc.21731 16404738
4. Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm? Aituov B, Duisembekova A, Bulenova A, Alibek K, Infectious agents and cancer 2012 7 1 18 10.1186/1750-9378-7-18 22873119
5. Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Alibek K, Kakpenova A, Baiken Y, Infectious agents and cancer 2013 8 1 7 10.1186/1750-9378-8-7 23374258
6. The role of infectious agents in urogenital cancers. Alibek K, Karatayeva N, Bekniyazov I, Infectious agents and cancer 2012 7 1 35 10.1186/1750-9378-7- 35 23198689
7. Cancer-related inflammation. Mantovani A, Allavena P, Sica A, Balkwill F, Nature 2008 454 7203 436 444 10.1038/nature07205 18650914
8. Infections and cancer: established associations and new hypotheses. de Martel C, Franceschi S, Critical reviews in oncology/hematology 2009 70 183 194 10.1016/j.critrevonc.2008.07.021 18805702
9. Mechanisms linking pathogens-associated inflammation and cancer. Porta C, Riboldi E, Sica A, Cancer letters 2011 305 250 262 10.1016/j.canlet.2010.10.012 21093147
10. Inflammation and cancer: how hot is the link? Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G, Biochemical pharmacology 2006 72 1605 1621 10.1016/j.bcp.2006.06.029 16889756 (Pubitemid 44666739)
11. Inflammation, a key event in cancer development. Lu H, Ouyang W, Huang C, Molecular cancer research: MCR 2006 4 221 233 10.1158/1541-7786.MCR-05-0261 16603636
12. The possible involvement of virus in breast cancer. Amarante MK, Watanabe MA, J Cancer Res Clin Oncol 2009 135 3 329 337 10.1007/s00432-008-0511-2 19009309
13. Is Epstein-Barr virus associated with aggressive forms of breast cancer? Khan G, Philip PS, Al Ashari M, Br J Cancer 2011 104 8 1362 1363 author reply 1364 10.1038/bjc.2011.99 21448167
14. Localization of Epstein-Barr virus to infiltrating lymphocytes in breast carcinomas and not malignant cells. Khan G, Philip PS, Al Ashari M, Houcinat Y, Daoud S, Exp Mol Pathol 2011 91 1 466 470 10.1016/j.yexmp.2011.04.018 21600202
15. Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone JM, Martin PM, Br J Cancer 2011 104 2 332 337 10.1038/sj.bjc.6606048 21179039
16. Epstein-Barr virus and breast cancer: serological study in a high-incidence area of nasopharyngeal carcinoma. He JR, Tang LY, Yu DD, Su FX, Song EW, Lin Y, Wang SM, Lai GC, Chen WQ, Ren ZF, Cancer Lett 2011 309 2 128 136 10.1016/j.canlet.2011.05.012 21724319
17. Joint effects of Epstein-Barr virus and polymorphisms in interleukin-10 and interferon-γ on breast cancer risk. He JR, Chen LJ, Su Y, Cen YL, Tang LY, Yu DD, Chen WQ, Wang SM, Song EW, Ren ZF, J Infect Dis 2012 205 1 64 71 10.1093/infdis/jir710 22095765
18. Epstein-Barr virus infection and sporadic breast cancer risk: a meta-analysis. Huo Q, Zhang N, Yang Q, PLoS One 2012 7 2 31656 10.1371/journal.pone.0031656 22363698
19. Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Harkins LE, Matlaf LA, Soroceanu L, Klemm K, Britt WJ, Wang W, Bland KI, Cobbs CS, Herpesviridae 2010 1 1 8 10.1186/2042-4280-1-8 21429243
20. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H, Br J Cancer 2010 102 11 1665 1669 10.1038/sj.bjc.6605675 20407437
21. Genetic markers of immunoglobulin G and susceptibility to breast cancer. Pandey JP, Kistner-Griffin E, Iwasaki M, Bu S, Deepe R, Black L, Kasuga Y, Hamada GS, Tsugane S, Hum Immunol 2012 73 11 1155 1158 10.1016/j.humimm.2012.07. 340 22884983
22. Exploring the prevalence of ten polyomaviruses and two herpes viruses in breast cancer. Antonsson A, Bialasiewicz S, Rockett RJ, Jacob K, Bennett IC, Sloots TP, PLoS One 2012 7 8 39842 10.1371/journal.pone.0039842 22916092
23. Is human cytomegalovirus associated with breast cancer progression? Utrera-Barillas D, Valdez-Salazar HA, Gomez-Rangel D, Alvarado-Cabrero I, Aguilera P, Gomez-Delgado A, Ruiz-Tachiquin ME, Infectious agents and cancer 2013 8 1 12 10.1186/1750-9378-8-12 23557440
24. Consensus on the role of human cytomegalovirus in glioblastoma. Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L, Cobbs CS, Neuro-oncology 2012 14 3 246 255 10.1093/neuonc/nor227 22319219
25. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Loenen WA, Bruggeman CA, Wiertz EJ, Seminars in immunology 2001 13 1 41 49 10.1006/smim.2001.0294 11289798 (Pubitemid 32304224)
26. Role of interleukin-10 in breast cancer. Hamidullah, Changkija B, Konwar R, Breast cancer research and treatment 2012 133 1 11 21 10.1007/s10549-011- 1855-x 22057973
27. Investigation of human JC and BK polyomaviruses in breast carcinomas. Hachana M, Amara K, Ziadi S, Gacem RB, Korbi S, Trimeche M, Breast cancer research and treatment 2012 133 3 969 977 10.1007/s10549-011-1876-5 22108781
28. No evidence for the involvement of XMRV or MCV in the pathogenesis of breast cancer. Khan G, Philip PS, Naase M, Al Zarouni KM, British journal of cancer 2012 106 6 1166 1170 10.1038/bjc.2012.51 22343621
29. New developments about the association of SV40 with human mesothelioma. Carbone M, Pass HI, Miele L, Bocchetta M, Oncogene 2003 22 33 5173 5180 10.1038/sj.onc.1206552 12910254 (Pubitemid 37059598)
30. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL, The New England journal of medicine 1992 326 15 988 993 10.1056/NEJM199204093261504 1312224
31. SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases. Galateau-Salle F, Bidet P, Iwatsubo Y, Gennetay E, Renier A, Letourneux M, Pairon JC, Moritz S, Brochard P, Jaurand MC, et al. The Journal of pathology 1998 184 3 252 257 10.1002/(SICI)1096-9896(199803)184:3<252::AID-PATH15>3.0.CO;2-R 9614376 (Pubitemid 28112780)
32. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Martini F, Iaccheri L, Lazzarin L, Carinci P, Corallini A, Gerosa M, Iuzzolino P, Barbanti-Brodano G, Tognon M, Cancer research 1996 56 20 4820 4825 8841004 (Pubitemid 26338090)
33. Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice. Wu M, Jung L, Cooper AB, Fleet C, Chen L, Breault L, Clark K, Cai Z, Vincent S, Bottega S, et al. Proc Natl Acad Sci USA 2009 106 17 7022 7027 10.1073/pnas.0811785106 19369208
34. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer. Hoenerhoff MJ, Shibata MA, Bode A, Green JE, Transgenic research 2011 20 2 247 259 10.1007/s11248-010-9406-5 20549348
35. Signal transduction in transgenic mouse models of human breast cancer-implications for human breast cancer. Marcotte R, Muller WJ, Journal of mammary gland biology and neoplasia 2008 13 3 323 335 10.1007/s10911-008-9087-3 18651209
36. Effects of simian virus 40 T-antigens on normal human mammary epithelial cells reveal evidence for spontaneous alterations in addition to loss of p16(INK4a) expression. Huschtscha LI, Neumann AA, Noble JR, Reddel RR, Experimental cell research 2001 265 1 125 134 10.1006/excr.2001.5178 11281650 (Pubitemid 32989070)
37. Evidence for a role of the Simian virus 40 in human breast carcinomas. Hachana M, Trimeche M, Ziadi S, Amara K, Korbi S, Breast cancer research and treatment 2009 113 1 43 58 10.1007/s10549-008-9901-z 18205041
38. Large T antigen promotes JC virus replication in G2-arrested cells by inducing ATM- and ATR-mediated G2 checkpoint signaling. Orba Y, Suzuki T, Makino Y, Kubota K, Tanaka S, Kimura T, Sawa H, The Journal of biological chemistry 2010 285 2 1544 1554 10.1074/jbc.M109.064311 19903823
39. JC virus mediates invasion and migration in colorectal metastasis. Link A, Shin SK, Nagasaka T, Balaguer F, Koi M, Jung B, Boland CR, Goel A, PloS one 2009 4 12 8146 10.1371/journal.pone.0008146 19997600
40. Human papillomaviruses. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer 2007 90 1 636 18354839
41. The role of human papillomavirus infection in breast cancer. Wang T, Chang P, Wang L, Yao Q, Guo W, Chen J, Yan T, Cao C, Med Oncol 2012 29 1 48 55 10.1007/s12032-010-9812-9 21318737
42. Prevalence of human papillomavirus in breast cancer: a systematic review. Simoes PW, Medeiros LR, Simoes Pires PD, Edelweiss MI, Rosa DD, Silva FR, Silva BR, Rosa MI, Int J Gynecol Cancer 2012 22 3 343 347 10.1097/IGC. 0b013e31823c712e 22214962
43. Are viruses associated with human breast cancer? Scrutinizing the molecular evidence-response to James F. Holland and Beatriz GT Pogo. Joshi D, Buehring GC, Breast Cancer Res Treat 2012 136 1 303 307 10.1007/s10549-012-2078- 5 22562175
44. HPV L1 capsid protein detection and progression of anal squamous neoplasia. Hernandez J, Elahi A, Siegel E, Coppola D, Riggs B, Shibata D, American journal of clinical pathology 2011 135 3 436 441 10.1309/ AJCPR5VD6NSQRWBN 21350099
45. Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. Glenn WK, Heng B, Delprado W, Iacopetta B, Whitaker NJ, Lawson JS, PloS one 2012 7 11 48788 10.1371/journal.pone.0048788 23183846
46. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Yasmeen A, Bismar TA, Kandouz M, Foulkes WD, Desprez PY, Al Moustafa AE, Cell cycle (Georgetown, Tex) 2007 6 16 2038 2042 10.4161/cc.6.16.4555 (Pubitemid 47327892)
47. High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Akil N, Yasmeen A, Kassab A, Ghabreau L, Darnel AD, Al Moustafa AE, British journal of cancer 2008 99 3 404 407 10.1038/sj.bjc.6604503 18648363
48. Evaluation of E6 and E7 mRNA expression in HPV DNA positive breast cancer. Frega A, Lorenzon L, Bononi M, De Cesare A, Ciardi A, Lombardi D, Assorgi C, Gentile M, Moscarini M, Torrisi MR, et al. European journal of gynaecological oncology 2012 33 2 164 167 22611956
49. Mammary epithelial cell transformation: insights from cell culture and mouse models. Dimri G, Band H, Band V, Breast cancer research: BCR 2005 7 4 171 179 10.1186/bcr1275 15987472 (Pubitemid 40872783)
50. Mechanisms of breast cancer. Imyanitov EN, Hanson KP, Drug Discovery Today: Disease Mechanisms 2004 1 2 235 245 10.1016/j.ddmec.2004.09.002 (Pubitemid 41128978)
51. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Ferber MJ, Thorland EC, Brink AA, Rapp AK, Phillips LA, McGovern R, Gostout BS, Cheung TH, Chung TK, Fu WY, et al. Oncogene 2003 22 46 7233 7242 10.1038/sj.onc.1207006 14562053 (Pubitemid 37378556)
52. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. McMurray HR, McCance DJ, Journal of virology 2003 77 18 9852 9861 10.1128/JVI.77.18.9852-9861.2003 12941894 (Pubitemid 37122066)
53. Activation of c-Myc contributes to bovine papillomavirus type 1 E7-induced cell proliferation. Fan X, Liu Y, Chen JJ, The Journal of biological chemistry 2003 278 44 43163 43168 10.1074/jbc.M306008200 12937171 (Pubitemid 37345935)
54. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. Gewin L, Galloway DA, Journal of virology 2001 75 15 7198 7201 10.1128/JVI.75.15.7198-7201.2001 11435602 (Pubitemid 32641609)
55. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. DeFilippis RA, Goodwin EC, Wu L, DiMaio D, J Virol 2003 77 2 1551 1563 10.1128/JVI.77.2.1551-1563.2003 12502868 (Pubitemid 36055574)
56. HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity. Wang YW, Chang HS, Lin CH, Yu WC, The international journal of biochemistry & cell biology 2007 39 2 402 412 10.1016/j.biocel.2006.09.006 20833257 (Pubitemid 44873096)
57. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer. Aceto GM, Solano AR, Neuman MI, Veschi S, Morgano A, Malatesta S, Chacon RD, Pupareli C, Lombardi M, Battista P, et al. Breast cancer research and treatment 2010 122 3 671 683 10.1007/s10549-009-0596-6 19851859
58. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. de Villiers EM, International journal of cancer Journal international du cancer 2003 103 6 705 708 10.1002/ijc.10868 12516087 (Pubitemid 36110224)
59. The mammary tumor agent in extracts of frozen and unfrozen mammary cancers. Bittner JJ, Imagawa DT, Cancer research 1953 13 7:1 525 528 13067070
60. Possibilities of a viral etiology for human breast cancer-A review. Pogo BGT, Holland JF, Biol Trace Elem Res 1997 56 131 142 ST-Possibilities of a viral etiology for human breast cancer-A review 10.1007/BF02778989 9152517 (Pubitemid 27198256)
61. Mouse mammary tumor virus-like sequences in human breast cancer. Lawson JS, Glenn WK, Salmons B, Ye Y, Heng B, Moody P, Johal H, Rawlinson WD, Delprado W, Lutze-Mann L, et al. Cancer Res 2010 70 9 3576 3585 10.1158/0008-5472.CAN-09- 4160 20388779
62. Genes affected by mouse mammary tumor virus (MMTV) proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors. Callahan R, Mudunur U, Bargo S, Raafat A, McCurdy D, Boulanger C, Lowther W, Stephens R, Luke BT, Stewart C, et al. Oncotarget 2012 3 11 1320 1334 23131872
63. 329 Expression of MMTV-homologous sequences in the patients with breast hyperplasia and ductal carcinoma in Situ. Zenit-Zhuravleva EG, Lushnikova AA, Lyubchenko LN, Polevaya EB, Eur J Cancer 2012 48, Supplement 1 0 139
64. High prevalence of MMTV-like env gene sequences in gestational breast cancer. Wang Y, Melana SM, Baker B, Bleiweiss I, Fernandez-Cobo M, Mandeli JF, Holland JF, Pogo BGT, Med Oncol 2003 20 3 233 236 10.1385/MO:20:3:233 14514972 (Pubitemid 37193934)
65. Inflammatory breast cancer in Tunisia in the era of multimodality therapy. Labidi SI, Mrad K, Mezlini A, Ouarda MA, Combes JD, Ben Abdallah M, Ben Romdhane K, Viens P, Ben Ayed F, Annals of oncology: official journal of the European Society for Medical Oncology / ESMO 2008 19 473 480 (Pubitemid 351325667)
66. Human mammary tumor virus in inflammatory breast cancer. Pogo BGT, Holland JF, Levine PH, Cancer 2010 116 2741 2744 ST-Human Mammary Tumor Virus in Inflammatory Breast Cancer 10.1002/cncr.25179 20503403
67. Kim HH, Grande SM, Monroe JG, Ross SR, Mouse Mammary Tumor Virus Suppresses Apoptosis of Mammary Epithelial Cells through ITAM-Mediated Signaling 2012
68. Hallmarks of cancer: of all cancer cells, all the time? Floor SL, Dumont JE, Maenhaut C, Raspe E, Trends Mol Med 2012 18 9 509 515 10.1016/j.molmed.2012. 06.005 22795735
69. Hallmarks of cancer: of all cancer cells, all the time? Floor SL, Dumont JE, Maenhaut C, Raspe E, Trends Mol Med 2012 18 9 509 515 10.1016/j.molmed.2012. 06.005 22795735
70. Using antimicrobial adjuvant therapy in cancer treatment: a review. Alibek K, Bekmurzayeva A, Mussabekova A, Sultankulov B, Infectious Agents and Cancer 2012 7 1 33 10.1186/1750-9378-7-33 23164412